These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. Rich S; Martinez J; Lam W; Levy PS; Rosen KM Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224 [No Abstract] [Full Text] [Related]
8. Unpredictable response to vasodilator therapy in primary pulmonary hypertension. Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697 [TBL] [Abstract][Full Text] [Related]
9. [Anorexic preparations and primary pulmonary hypertension]. Ugriumova MO Ter Arkh; 1976; 40(2):126-31. PubMed ID: 788209 [No Abstract] [Full Text] [Related]
10. Neonatal 'pulmonary vasodilator' drugs. Current status. Drummond WH; Lock JE Dev Pharmacol Ther; 1984; 7(1):1-20. PubMed ID: 6421557 [TBL] [Abstract][Full Text] [Related]
11. [Effect of lung resection on the decrease of hypertension in the pulmonary artery by means of drugs]. Lenz J; Hartel W; Schuster G; Kohlhepp E Thoraxchir Vask Chir; 1970 Feb; 18(1):27-33. PubMed ID: 5265955 [No Abstract] [Full Text] [Related]
12. The reversibility of pulmonary hypertension in patients with cystic fibrosis. Observations on the effects of tolazoline hydrochloride. Kelminson LL; Cotton EK; Vogel JH Pediatrics; 1967 Jan; 39(1):24-35. PubMed ID: 6016228 [No Abstract] [Full Text] [Related]
13. [Chronic pulmonary hypertension of vascular etiology, plexogenic pulmonary arteriopathy and the appetite depressant Aminorex: lessons from an epidemic]. Gurtner HP Schweiz Med Wochenschr; 1985 Jun; 115(24):818-27. PubMed ID: 4012251 [No Abstract] [Full Text] [Related]
14. Editorial: Progressive pulmonary hypertension in children with portal hypertension. Haworth SG; Hislop A; Reid L J Pediatr; 1974 May; 84(5):783-5. PubMed ID: 4595099 [No Abstract] [Full Text] [Related]
16. [Therapy of primary pulmonary hypertension]. Both A Z Kreislaufforsch; 1970 Oct; 59(10):909-11. PubMed ID: 4992357 [No Abstract] [Full Text] [Related]
17. [Heart pathology of extracardiac origin. IV. Pulmonary hypertension in chronic respiratory diseases]. Barberà JA Rev Esp Cardiol; 1998 Jan; 51(1):56-68. PubMed ID: 9522610 [TBL] [Abstract][Full Text] [Related]
18. [Oxygen and tolazoline as vasodilators in pulmonary arterial hypertension secondary to high pulmonary blood flow]. Salgado-Escobar JL; Ledesma-Velasco M; Munayer-Calderón J; Núñez-Garduño D; Salas-López ME; Rodríguez-Hernández L Bol Med Hosp Infant Mex; 1987 Mar; 44(3):137-42. PubMed ID: 3580096 [No Abstract] [Full Text] [Related]
19. A problem in pulmonary hypertension. 2. The final course and autopsy findings. A clinicopathologic conference from the Division of Pulmonary Diseases, Hahnemann Medical College and Hospital, Philadelphia. Chest; 1974 Feb; 65(2):192-7. PubMed ID: 4810679 [No Abstract] [Full Text] [Related]
20. Pulmonary flow reserve in children with idiopathic pulmonary arterial hypertension: implications for diagnosis and therapy. Zimmermann R; Kreuder J; Michel-Behnke I; Voelkel NF; Schranz D Eur J Med Res; 2006 May; 11(5):208-13. PubMed ID: 16723295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]